Drugs / Dl-Alpha Tocopheryl Acetate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01413620 | Aug 2011 → Aug 2017 | — | Shriners Hospitals for Children | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02620345 Background | Jan 2010 → Oct 2015 | benign neoplasm of corpus uteri | Trieu, Nguyen Thi, M.D. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dl-Alpha Tocopheryl Acetate | “Cholecalciferol 400 IU/day Dl-Alpha Tocopheryl Acetate 11IU Thiamin Mononitrate 1.5 mg/day” NCT02620345 ↗ |
| Action | Restore | “restore levels of vitamin E in adipose tissue” NCT01413620 ↗ |
| Route | Oral | “The dose of aqueous vitamin E (Aqueous Vitamin E Oral Drops, Silarx, No. 54838-0005-30, Spring Valley, NY) will be given orally.” NCT01413620 ↗ |